Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes

The therapeutic efficacy of biochemotherapy in metastatic malignant melanoma still carries a low remission rate, but with some durable responses. It would therefore be of considerable importance if patients with a high probability of responding could be identified using predictive tests. The respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Håkansson, A, Gustafsson, B, Krysander, L, Hjelmqvist, B, Rettrup, B, Håkansson, L
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364006/
https://www.ncbi.nlm.nih.gov/pubmed/11747328
http://dx.doi.org/10.1054/bjoc.2001.2169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364006/
https://www.ncbi.nlm.nih.gov/pubmed/11747328
http://dx.doi.org/10.1054/bjoc.2001.2169

Ejemplares similares